Form 4 for CMMB Chemomab Therapeutics Ltd.
Accepted 2026-06-01 07:33:22 ET · period of report 2026-05-29 · accession 0001178913-26-003004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-01 07:33 | 2026-05-29 | CMMB | Mor George Adi | CEO, Dir | P - Purchase | $2.07 | -9,804 | 139.1K | -7% | -$20.2K |
| M | 2026-06-01 07:33 | 2026-05-29 | CMMB | Mor George Adi | CEO, Dir | J - Other | — | -50.5K | 18.8K | -73% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-05-29 | P | D | 4,878 | $2.05 | 134,205 | D | — | — | |
| 2 | Common | American Depositary Shares | 2026-05-29 | P | D | 4,926 | $2.08 | 139,131 | D | — | — | |
| 3 | Common | American Depositary Shares | 2026-05-29 | J | D | 31,712 | — | 31,712 | D | — | — | (F2) The American Depositary Shares reported in this row consist of restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer on November 18, 2024, and vest and become exercisable according to following schedule: 25% on October 1, 2025, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on October 1, 2028. (F1) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. |
| 4 | Common | American Depositary Shares | 2026-05-29 | J | D | 18,750 | — | 18,750 | D | — | — | (F3) The American Depositary Shares reported in this row consist of RSUs that were granted to the Reporting Person by the Issuer on July 1, 2025 vest and become exercisable according to following schedule: 25% on April 10, 2026, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on April 10, 2029. (F1) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. |